CGON vs GILD: Which Stock is Better?

Side-by-side comparison of Cg Oncology Inc and Gilead Sciences Inc in 2026

Comparison Updated:

CGON

Cg Oncology Inc

$73.43

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricCGONGILDWinner
Market Cap$6.20B$170.84BGILD
P/E RatioN/A20.27GILD
EPS (TTM)$N/A$6.79GILD
Revenue Growth4.1%0.0%CGON
Gross Margin-2902.2%78.8%GILD

Analyze CGON

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGON or GILD a better investment?

Comparing CGON and GILD: Cg Oncology Inc has a market cap of $6.20B while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGON and GILD?

CGON (Cg Oncology Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGON or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CGON or GILD?

CGON has higher revenue growth at 4.1% vs 0.0% for GILD.

Which company is more profitable: CGON or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -2902.2% for CGON.

Which is the larger company: CGON or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $6.20B for CGON.

Should I buy CGON or GILD in 2026?

Both CGON and GILD have investment merit. CGON trades at $73.43 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGON and GILD stock?

Key differences: Market Cap ($6.20B vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (4.1% vs 0.0%), Gross Margin (-2902.2% vs 78.8%).

Popular Stock Comparisons